Pic: Getty Images
Top 10 at 11ish: Chimeric Therapeutics soars 58pc on US FDA clearance
News
share
Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading – for better or worse.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| CHM | Chimeric Therapeutic | 0.041 | 58% | 12,929,127 | $13,889,277 |
| NNG | Nexion Group | 0.019 | 46% | 568,874 | $2,630,002 |
| FZR | Fitzroy River Corp | 0.15 | 36% | 15,000 | $11,874,968 |
| ENT | Enterprise Metals | 0.004 | 33% | 1,277,948 | $2,398,413 |
| TOY | Toys R Us | 0.014 | 27% | 3,690,875 | $10,807,099 |
| KPO | Kalina Power Limited | 0.005 | 25% | 101,029 | $6,060,783 |
| EDE | Eden Inv Ltd | 0.003 | 20% | 101,374 | $8,409,092 |
| GHY | Gold Hydrogen | 0.31 | 19% | 182,626 | $14,799,986 |
| KRR | King River Resources | 0.02 | 18% | 2,654,644 | $26,409,924 |
| PGM | Platina Resources | 0.027 | 17% | 27,880 | $14,333,148 |
Chimeric Therapeutics (ASX:CHM) is up 58% in opening trade after the US Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of CHM 2101, the company’s first in class CDH17 CAR T cell therapy for gastrointestinal cancers.
CHM plans to investigate CHM 2101 in a multi-centre, open label Phase 1A/B clinical trial for patients with advanced colorectal cancer, gastric cancer and neuroendocrine tumours.
Gold Hydrogen (ASX:GHY) is up after announcing significant concentrations of hydrogen and helium have found at the Ramsay 1 well, confirming historic measurement and demonstrating an active hydrogen system in the Ramsay Project area, on South Australia’s Yorke Pennisula.
Testing and laboratory results measured air-corrected hydrogen at 73.3% at 240m below ground level, consistent with the 76% air-corrected concentration of hydrogen reported in the Ramsay Oil Bore 1 in 1931.
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| MTH | Mithril Resources | 0.001 | -33% | 33,334 | $5,053,207 |
| RAD | Radiopharm | 0.08 | -20% | 590,095 | $23,931,304 |
| SFG | Seafarms Group | 0.004 | -20% | 9,388 | $24,182,996 |
| MDI | Middle Island Resources | 0.019 | -17% | 786,972 | $3,235,139 |
| CRB | Carbine Resources | 0.005 | -17% | 988,294 | $3,310,427 |
| ASH | Ashley Services Grp | 0.44 | -15% | 138,459 | $74,147,591 |
| BSE | Base Res Limited | 0.12 | -14% | 1,713,970 | $164,921,659 |
| IEC | Intra Energy Corp | 0.0035 | -13% | 7,094 | $6,643,126 |
| MKG | Mako Gold | 0.014 | -13% | 700,416 | $9,216,131 |
| XPN | Xpon Technologies | 0.035 | -13% | 500 | $6,341,101 |
Gold explorer Middle Island Resources (ASX:MDI) has fallen this morning after announcing a capital raise. MDI says it seeks to raise a minimum of $1 million and up to $1, 054,937, before costs via a pro rata renounceable rights offer.
